Lens (anatomy)

Clearly makes history by becoming Canada's first-ever eyewear retailer to offer direct billing online

Retrieved on: 
Wednesday, November 9, 2022
Kid, Blue Cross, Black and Indian Mission office, Lens (anatomy), TELUS, Canada Life, Program, History, Insurance, Clearly, Online shopping, BC

VANCOUVER, BC, Nov. 9, 2022 /CNW/ - Clearly has become the first e-commerce optical provider in Canada to offer online direct billing to eyewear customers.

Key Points: 
  • VANCOUVER, BC, Nov. 9, 2022 /CNW/ - Clearly has become the first e-commerce optical provider in Canada to offer online direct billing to eyewear customers.
  • Clearly makes history by becoming Canada's first-ever eyewear retailer to offer direct billing online.
  • Until now, direct billing has not existed in the online eyewear market, forcing shoppers who buy their eyewear online to pay for their vision needs and then submit a claim to their insurance provider for reimbursement.
  • "This is truly a revolutionary platform in the online Canadian eyecare sphere, and we are so proud to be the first to implement online direct billing.

MediPrint™ Ophthalmics Announces It Has Initiated Its SIGHT-2 Phase 2b Clinical Study for Its Lead Asset

Retrieved on: 
Tuesday, November 8, 2022
Health, Clinical Trials, Research, Pharmaceutical, Science, Optical, Glaucoma, CBCC, Neurology, Patient, FDA, Company, Psychiatry, Ocular hypertension, Interim, Trial of the century, Life, Disease, GMP, Data management, Safety management system, Allergy, ISO, Eye disease, Lens (anatomy), Research, Safety, CEO, Pharmaceutical industry, Ophthalmology, Oncology

Today, MediPrint Ophthalmics, an emerging San Diego-based clinical stage eye care pharmaceutical company focused on enhancing vision for life, announces it has initiated its SIGHT-2 dose-finding Phase 2b study for its proprietary drug-eluting contact lens for glaucoma.

Key Points: 
  • Today, MediPrint Ophthalmics, an emerging San Diego-based clinical stage eye care pharmaceutical company focused on enhancing vision for life, announces it has initiated its SIGHT-2 dose-finding Phase 2b study for its proprietary drug-eluting contact lens for glaucoma.
  • Consequently, MediPrint is proceeding with this previously announced SIGHT-2 study for LL-BMT1, a weekly medicated contact lens releasing bimatoprost to treat open angle glaucoma and ocular hypertension.
  • MediPrint has retained CBCC Global Research to facilitate the regulatory, clinical operations, data management and biometric services for the SIGHT-2 study.
  • CBCC offers end-to-end services for clinical trials, including clinical operations, site management, safety management, clinical data management & statistical analysis and medical & scientific writing.

Black Friday is Here: Unicoeye Kicks Off the Holiday Shopping Season Early

Retrieved on: 
Wednesday, November 9, 2022
Friends, Nature, FDA, Collection, Love, Premium, Lens, Beauty, Family, Lens (anatomy), Black Friday, Holiday, Multimedia, Sale, Technology, Retail, Cosmetics

This year the deals will include discounts on colored contacts and gifts that customers can take advantage of before and after Black Friday.

Key Points: 
  • This year the deals will include discounts on colored contacts and gifts that customers can take advantage of before and after Black Friday.
  • "Nowadays, many people start their holiday shopping early, so we want to make sure they have the best deals to look forward to," said theUnicoeyeteam.
  • "We're excited to be part of this holiday shopping season and are well-prepared for it.
  • Anyone looking for amazing discounts on trendy colored contact lenses can check out Unicoeye'swebsite during the holiday shopping season.

Bausch + Lomb Announces Participation at the 5th Annual Evercore ISI HealthCONx Conference

Retrieved on: 
Monday, November 7, 2022
Investor relations, NYSE, Bausch & Lomb, Lens (anatomy), Bausch, Pharmaceutical industry

A live webcast and audio archive of the conferences will be available on the Investor Relations page of the Bausch + Lomb website at: https://ir.bausch.com/investors/events-presentations .

Key Points: 
  • A live webcast and audio archive of the conferences will be available on the Investor Relations page of the Bausch + Lomb website at: https://ir.bausch.com/investors/events-presentations .
  • Bausch + Lomb is dedicated to protecting and enhancing the gift of sight for millions of people around the world from the moment of birth through every phase of life.
  • Founded in 1853, Bausch + Lomb has a significant global research and development, manufacturing and commercial footprint with more than 12,000 employees and a presence in nearly 100 countries.
  • Bausch + Lomb is headquartered in Vaughan, Ontario with corporate offices in Bridgewater, New Jersey.

China Contact Lenses Market 2023-2028: Social Media Influencing Increased Sales and Sector Growth - ResearchAndMarkets.com

Retrieved on: 
Friday, November 4, 2022
Retail, Specialty, Optical, Health, Astigmatism, Lens (anatomy), UV, Social media, Forecasting, Quotations from Chairman Mao Tse-tung, Food delivery

The "China Contact Lenses Market 2023-2028" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "China Contact Lenses Market 2023-2028" report has been added to ResearchAndMarkets.com's offering.
  • The contact lenses market in China is expected to proliferate at CAGRs of 8.57% (in terms of revenue) and 6.92% (in terms of volume) during the forecasting period between 2023 and 2028.
  • With Chinese consumers becoming increasingly knowledgeable and sophisticated, the demand for contact lenses is also observed to be on the rise.
  • In particular, more and more consumers are open to purchasing customized contact lenses that have inbuilt astigmatism correction.

CooperVision Adds SynergEyes to Expand Specialty Contact Lens Adoption in North America

Retrieved on: 
Thursday, November 3, 2022
Presbyopia, Woman, SAN, Lens (anatomy), OD, Astigmatism, Workforce, Keratoconus, Fertility, Cooper, CooperVision, The Cooper Companies, Duette, Florida, Health, Cornea, Adoption, NYSE, Progressive lens, Genomics, Telescopic sight, Medicine, Paragon

SAN RAMON, Calif., Nov. 3, 2022 /PRNewswire/ -- Deepening its commitment to expand specialty contact lens adoption in North America and worldwide, CooperVision has added SynergEyes to its CooperVision Specialty EyeCare business unit. The Carlsbad, Calif.-based company is widely known for hybrid lens technologies and brands, which span the treatment of irregular cornea, presbyopia, and astigmatism.

Key Points: 
  • SAN RAMON, Calif., Nov. 3, 2022 /PRNewswire/ -- Deepening its commitment to expand specialty contact lens adoption in North America and worldwide, CooperVision has added SynergEyes to its CooperVision Specialty EyeCare business unit.
  • "Eye care practitioners are searching for ways to differentiate themselves, with a growing number embracing specialty contact lenses for their clinical and business advantages.
  • "SynergEyes offers a broad range of specialty contact lenses, including proprietary hybrid lenses, complementing our popular Onefit scleral lenses.
  • Louise Sclafani, OD, FAAO, FSLS, Vice President of Professional Affairs for SynergEyes, will join the CooperVision Specialty EyeCare Americas team.

Global Vision Care Market Report 2022: Increase in Screen-Time Creating Eye Issues and Boosting Demand in Sector - ResearchAndMarkets.com

Retrieved on: 
Tuesday, November 1, 2022
Pharmaceutical, Optical, Health, Medical Supplies, Headache, Prevalence, Clifton Springs Hospital & Clinic, Growth, CAGR, Severe cognitive impairment, Lens (anatomy), SEE, Population, Hospital, COVID-19, Social media, Student, News, Eye disease, Retail, Marketing

The "Global Vision Care Market Research and Forecast 2022-2028" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Global Vision Care Market Research and Forecast 2022-2028" report has been added to ResearchAndMarkets.com's offering.
  • The global vision care market is growing at a considerable CAGR of 5.4% during the forecast period (2022-2028).
  • The major factors augmenting the growth of the market include rise in geriatric population and technological advancements in eye care.
  • Key companies operating in the global vision care market.

Bausch + Lomb #LUMIFYEyeDance Challenge Wins 2022 Public Relations and Marketing Excellence Award for External Campaign of the Year from Business Intelligence Group

Retrieved on: 
Tuesday, November 1, 2022
Canadian Securities Administrators, Marketing, BASES, News, Challenge, Time, NYSE, Industry, U.S. Securities and Exchange Commission, COVID-19, Bausch & Lomb, Surgery, Travel, Incidence, No, Dance, Glamour, Public relations, BIG, Lens (anatomy), IQVIA, Fear, Nightclub, Pharmaceutical industry

VAUGHAN, ON, Nov. 1, 2022 /PRNewswire/ -- Bausch + Lomb Corporation (NYSE/TSX: BLCO) ("Bausch + Lomb"), a leading global eye health company dedicated to helping people see better to live better, today announced the #LUMIFYEyeDance Challenge on TikTok has received Business Intelligence Group's (BIG) 2022 Public Relations and Marketing Excellence Award for External Campaign of the Year.

Key Points: 
  • VAUGHAN, ON, Nov. 1, 2022 /PRNewswire/ -- Bausch + Lomb Corporation (NYSE/TSX: BLCO) ("Bausch + Lomb"), a leading global eye health company dedicated to helping people see better to live better, today announced the #LUMIFYEyeDance Challenge on TikTok has received Business Intelligence Group's (BIG) 2022 Public Relations and Marketing Excellence Award for External Campaign of the Year.
  • To support the Challenge, Bausch + Lomb also held a sampling tour that ran through Chicago, Dallas, Los Angeles and New York during the month of August.
  • Since launching in 2018, Bausch + Lomb LUMIFY eye drops have received more than a dozen awards, including Glamour's "The Best Beauty Innovators of 2022" award.
  • The Business Intelligence Group was founded with the mission of recognizing true talent and superior performance in the business world.

FTC Returning More Than $1.9 Million to Consumers Nationwide Who Purchased Hubble Contact Lenses Without Properly Obtained or Verified Prescriptions

Retrieved on: 
Monday, October 31, 2022
Prescription, Commission, Maya Lauqué, Section, Congress, Lens (anatomy), Federal Trade Commission, Fraud, News, Supreme, Supreme court, Lens, FTC, Dietary supplement, Facebook, Hubble Space Telescope

The Federal Trade Commission is sending payments totaling more than $1.9 million to 30,172 consumers nationwide who bought Hubble brand contact lenses from Vision Path, Inc.

Key Points: 
  • The Federal Trade Commission is sending payments totaling more than $1.9 million to 30,172 consumers nationwide who bought Hubble brand contact lenses from Vision Path, Inc.
  • The Commission never requires consumers to pay money or provide account information to get a refund.
  • The Commission has urged Congress to restore the Commissions ability to get money back for consumers.
  • Like the FTC on Facebook, follow us on Twitter, get consumer alerts, read our blogs, and subscribe to press releases for the latest FTC news and resources.

The Worldwide Age-related Macular Degeneration Industry is Expected to Reach $14.4 Billion by 2030 - ResearchAndMarkets.com

Retrieved on: 
Thursday, October 27, 2022
Pharmaceutical, Health, Optical, Association, Presbyopia, Ranibizumab, Bevacizumab, PDT, Revenue, Adoption, Industry, Astigmatism, Myopia, FDA, AMD, Lens (anatomy), Visual impairment, Macular degeneration, Severe cognitive impairment, WHO, PRK, American Association, Far-sightedness, Thr, Approximation error, Pharmaceutical industry, Cryptocurrency, LASIK, Ophthalmology

The different types of refractive errors include nearsightedness (myopia), farsightedness (hyperopia), astigmatism, and presbyopia.

Key Points: 
  • The different types of refractive errors include nearsightedness (myopia), farsightedness (hyperopia), astigmatism, and presbyopia.
  • Glasses, contact lenses, and laser eye surgery are the commonly available treatment for the correction of refractive errors.
  • Furthermore, as per the American Refractive Surgery Council, in 2017, more than 29 million LASIK procedures were performed in the US.
  • The publisher has segmented the Age-related Macular Degeneration (AMD) Market report based on product, drugs, route of administration, distribution channel, and region:
    Age-related Macular Degeneration (AMD), Product Outlook (Revenue - USD Billion, 2018 - 2030)
    Age-related Macular Degeneration (AMD), Drugs Outlook (Revenue - USD Billion, 2018 - 2030)